HealthEquity financials
$87.25−1.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '27 Jul 31 | Q1 '27 Apr 30 | Q4 '26 Jan 31 | Q3 '26 Oct 31 | Q2 '26 Jul 31 | Q1 '26 Apr 30 | Q4 '25 Jan 31 | Q3 '25 Oct 31 | Q2 '25 Jul 31 | Q1 '25 Apr 30 | Q4 '24 Jan 31 | Q3 '24 Oct 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $350.7M | $354.6M | $334.6M | $322.2M | $325.8M | $330.8M | $311.8M | $300.4M | $299.9M | $287.6M | $262.4M | $249.2M |
| Gross profit | $258.0M | $256.3M | $228.1M | $228.1M | $232.6M | $224.3M | $189.0M | $197.0M | $204.1M | $187.1M | $163.3M | $159.2M |
| Gross margin | 73.5% | 72.3% | 68.2% | 70.8% | 71.4% | 67.8% | 60.6% | 65.6% | 68.0% | 65.1% | 62.2% | 63.9% |
| Operating income | $98.7M | $103.0M | $71.1M | $78.7M | $89.6M | $83.1M | $42.1M | $19.6M | $58.9M | $41.6M | $38.9M | $30.9M |
| Net income | $65.6M | $69.4M | $49.7M | $51.7M | $59.9M | $53.9M | $26.4M | $5.7M | $35.8M | $28.8M | $26.4M | $14.7M |
| Net margin | 18.7% | 19.6% | 14.9% | 16.0% | 18.4% | 16.3% | 8.5% | 1.9% | 11.9% | 10.0% | 10.0% | 5.9% |
| Diluted EPS | $0.78 | $0.82 | $0.57 | $0.59 | $0.68 | $0.61 | $0.29 | $0.06 | $0.40 | $0.33 | $0.30 | $0.17 |
| EBITDA | $141.6M | $142.3M | $111.1M | $118.6M | $129.3M | $123.1M | $83.5M | $94.8M | $104.3M | $82.7M | $41.2M | $71.3M |
| Operating cash flow | $136.2M | $97.5M | $117.9M | $138.6M | $135.9M | $64.7M | $75.7M | $90.5M | $108.1M | $65.4M | $77.1M | $57.1M |
| Free cash flow | $135.2M | $97.2M | $107.8M | $127.5M | $135.1M | $64.7M | $62.2M | $77.7M | $95.2M | $51.6M | $65.8M | $44.9M |
| Diluted shares | 84.0M | 85.0M | 86.8M | 87.0M | 87.7M | 88.4M | 89.7M | 88.6M | 88.6M | 88.3M | 88.3M | 87.1M |
Balance sheet
| Period end | Jul 31 | Apr 30 | Jan 31 | Oct 31 | Jul 31 | Apr 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $256.0M | $265.4M | $318.9M | $309.3M | $304.5M | $287.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $931.1M | $942.7M | $957.4M | $982.1M | $1.01B | $1.06B |
| Total assets | $3.27B | $3.31B | $3.38B | $3.40B | $3.42B | $3.42B |
| Total liabilities | $1.28B | $1.26B | $1.27B | $1.26B | $1.27B | $1.29B |
| Shareholders' equity | $1.99B | $2.05B | $2.11B | $2.13B | $2.15B | $2.12B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology